Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor.
Lino RC, da Silva DPB, Florentino IF, da Silva DM, Martins JLR, Batista DDC, Leite KCS, Villavicencio B, Vasconcelos GA, Silva ALP, de Ávila RI, Verli H, Valadares MC, Gil ES, Vaz BG, Lião LM, Menegatti R, Costa EA. Lino RC, et al. Among authors: verli h. Eur J Pharm Sci. 2017 Aug 30;106:231-243. doi: 10.1016/j.ejps.2017.06.006. Eur J Pharm Sci. 2017. PMID: 28599988
Induction of apoptosis in Ehrlich ascites tumour cells via p53 activation by a novel small-molecule MDM2 inhibitor - LQFM030.
da Mota MF, Cortez AP, Benfica PL, Rodrigues Bdos S, Castro TF, Macedo LM, Castro CH, Lião LM, de Carvalho FS, Romeiro LA, Menegatti R, Verli H, Villavicencio B, Valadares MC. da Mota MF, et al. Among authors: verli h. J Pharm Pharmacol. 2016 Sep;68(9):1143-59. doi: 10.1111/jphp.12573. Epub 2016 Jun 28. J Pharm Pharmacol. 2016. PMID: 27350017
Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization.
da Silva DPB, Florentino IF, da Silva DM, Lino RC, Cardoso CS, Moreira LKS, Vasconcelos GA, Vinhal DC, Cardoso ACD, Villavicencio B, Verli H, Vaz BG, Lião LM, da Cunha LC, Menegatti R, Costa EA. da Silva DPB, et al. Among authors: verli h. Inflammopharmacology. 2018 Oct;26(5):1189-1206. doi: 10.1007/s10787-018-0516-7. Epub 2018 Jul 23. Inflammopharmacology. 2018. PMID: 30039481
Novel choline analog 2-(4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol produces sympathoinhibition, hypotension, and antihypertensive effects.
Menegatti R, Carvalho FS, Lião LM, Villavicencio B, Verli H, Mourão AA, Xavier CH, Castro CH, Pedrino GR, Franco OL, Oliveira-Silva I, Ashpole NM, Silva ON, Costa EA, Fajemiroye JO. Menegatti R, et al. Among authors: verli h. Naunyn Schmiedebergs Arch Pharmacol. 2019 Sep;392(9):1071-1083. doi: 10.1007/s00210-019-01649-8. Epub 2019 May 2. Naunyn Schmiedebergs Arch Pharmacol. 2019. PMID: 31049606
Prediction, mapping and validation of tick glutathione S-transferase B-cell epitopes.
Ndawula C Jr, Amaral Xavier M, Villavicencio B, Cortez Lopes F, Juliano MA, Parizi LF, Verli H, da Silva Vaz I Jr, Ligabue-Braun R. Ndawula C Jr, et al. Among authors: verli h. Ticks Tick Borne Dis. 2020 Jul;11(4):101445. doi: 10.1016/j.ttbdis.2020.101445. Epub 2020 Apr 23. Ticks Tick Borne Dis. 2020. PMID: 32354639
Design, synthesis and pharmacological assessment of new pyrazole compounds.
Oliveria JC, Silva DPB, Florentino IF, da Silva LC, Sanz G, Vaz BG, Pazini F, de Carvalho FS, Lião LM, Dos Santos TRM, Valadares MC, Costa EA, Dos Santos FCA, Villavicencio B, Verli H, Menegatti R. Oliveria JC, et al. Among authors: verli h. Inflammopharmacology. 2020 Aug;28(4):915-928. doi: 10.1007/s10787-020-00727-1. Epub 2020 Jun 11. Inflammopharmacology. 2020. PMID: 32529601
L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke.
Carvalho GA, Chiareli RA, Marques BL, Parreira RC, de Souza Gil E, de Carvalho FS, da Rocha ALB, Silva RR, Noël F, Vaz BG, Lião LM, Ahmad S, Verli H, Menegatti R, Pinto MCX. Carvalho GA, et al. Among authors: verli h. Pharmacol Rep. 2023 Apr;75(2):276-292. doi: 10.1007/s43440-023-00451-x. Epub 2023 Jan 31. Pharmacol Rep. 2023. PMID: 36719635
98 results